Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study

被引:43
作者
Alkerwi, Ala'a [1 ,2 ]
Donneau, Anne-Francoise [2 ]
Sauvageot, Nicolas [1 ]
Lair, Marie-Lise [1 ]
Scheen, Andre [3 ]
Albert, Adelin [2 ]
Guillaume, Michele [2 ]
机构
[1] Ctr Etudes Sante, Ctr Rech Publ Sante CRP Sante, Luxembourg, Luxembourg
[2] Univ Liege, Sch Publ Hlth, B-4000 Liege, Belgium
[3] CHU Sart Tilman, Dept Med, B-4000 Liege, Belgium
关键词
INTERNATIONAL-DIABETES-FEDERATION; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; WAIST CIRCUMFERENCE; RISK; MORTALITY; POPULATION; VALIDATION; RATIONALE;
D O I
10.1186/1471-2458-11-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The prevalence of the metabolic syndrome (MS) has been determined in many countries worldwide but never in Luxembourg. This research aimed to 1) establish the gender-and age-specific prevalence of MS and its components in the general adult population of Luxembourg, according to the most recent Joint Interim Statement (JIS) definition, by using both the high and low cut-off points to define abdominal obesity, and 2) compare and assess the degree of agreement with the Revised National Cholesterol Education Programme-Adult Treatment Panel III (R-ATPIII) and the International Diabetes Federation (IDF) definitions. Methods: A representative stratified random sample of 1349 European subjects, aged 18-69 years, participated to ORISCAV-LUX survey. Logistic regression and odds ratios (OR) were used to study MS prevalence with respect to gender and age. The Framingham risk score (FRS) to predict the 10-year coronary heart disease (CHD) risk was calculated to compare the proportion of MS cases below or above 20%, according to both high and low waist circumference (WC) thresholds. Cohen's kappa coefficient (kappa) was utilized to measure the degree of agreement between MS definitions. Results: The prevalence of the MS defined by the JIS was 28.0% and 24.7% when using the low (94/80) and the high (102/88) WC cut-off points, respectively. The prevalence was significantly higher in men than in women (OR = 2.6 and 2.3 for the low and high WC thresholds), as were all components of the MS except abdominal obesity measured by both thresholds. It also increased with age (OR values in age categories ranging from 2.7 to 28 when compared to the younger subjects for low WC and from 3.3 to 31 for the high WC cut-offs). The 10-year predicted risk of CHD by FRS did not depend on the threshold used. Globally, excellent agreement was observed between the three definitions of MS (kappa = 0.89), in particular between JIS and IDF (kappa = 0.93). Agreement was significantly higher in women than in men, and differed between age groups. Conclusion: Regardless of the definition used, the adult population of Luxembourg reveals a high MS prevalence. Our findings contribute to build evidence regarding the definitive construct of the MS, to help selecting the waist circumference thresholds for Europid populations, and to support the need to revise the guidelines for abdominal obesity levels.
引用
收藏
页数:9
相关论文
共 36 条
[1]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[2]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]   The influence of age and body mass index on the metabolic syndrome and its components [J].
Alexander, C. M. ;
Landsman, P. B. ;
Grundy, Scott M. .
DIABETES OBESITY & METABOLISM, 2008, 10 (03) :246-250
[6]  
ALKERWI A, 2010, BMC PUBLIC HLTH, V10
[7]   Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg [J].
Alkerwi, Ala'a ;
Sauvageot, Nicolas ;
Couffignal, Sophie ;
Albert, Adelin ;
Lair, Marie-Lise ;
Guillaume, Michele .
BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
[8]  
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[9]  
Anand SS, 1998, CAN J CARDIOL, V14, P1349
[10]  
[Anonymous], 2000, WHO TECH REP SER, V894, pi